FDA Will Raise Bar For Supplement GMP Compliance – NPA
This article was originally published in The Tan Sheet
Executive Summary
“FDA is training their inspectors faster than, I think, we’re training the industry,” says Natural Products Association VP Cara Welch. The regulatory affairs exec tells an Expo East audience the rate of supplement GMP inspections that observe violations remains unacceptably high.
You may also be interested in...
Basic GMP Failures Will Prompt Heightened FDA Scrutiny
FDA supplement programs director Dan Fabricant and food and drug law attorney Marc Ullman reflect on the ongoing struggles of many supplement firms to meet good manufacturing practice standards. “‘I don’t have the resources to comply’ is not an excuse. Then get out of the business,” Ullman says.
FDA Supplement Enforcement Priorities Go Beyond NDI Notification
FDA’s plan to tighten enforcement of new dietary ingredient notifications with its controversial guidance still in draft form raises concerns for some stakeholders.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.